IOT Stock Overview
Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.17|
|52 Week High||CA$0.23|
|52 Week Low||CA$0.12|
|1 Month Change||10.00%|
|3 Month Change||-13.16%|
|1 Year Change||0%|
|3 Year Change||153.85%|
|5 Year Change||73.68%|
|Change since IPO||-21.43%|
Recent News & Updates
Would Financials Be Able To Push Innovotech Inc.'s (CVE:IOT) Stock Prices Higher In The Near Future?
Looking at Innovotech's (CVE:IOT) mostly flat share price movement over the past week, it is easy to think that there’s...
|IOT||CA Life Sciences||CA Market|
Return vs Industry: IOT exceeded the Canadian Life Sciences industry which returned -19% over the past year.
Return vs Market: IOT exceeded the Canadian Market which returned -2.9% over the past year.
|IOT Average Weekly Movement||n/a|
|Life Sciences Industry Average Movement||11.4%|
|Market Average Movement||10.0%|
|10% most volatile stocks in CA Market||17.2%|
|10% least volatile stocks in CA Market||4.4%|
Stable Share Price: Insufficient data to determine IOT's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine IOT's volatility change over the past year.
About the Company
Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally. The company offers InnovoSIL, an antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and AgreGuard, an antimicrobial for crop protection. It also provides implant medical devices; antibiotic, antimicrobial, and biocide resistance; biofilm eradication surface and MBEC Assay testing; and analytical services.
Innovotech Fundamentals Summary
|IOT fundamental statistics|
Is IOT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|IOT income statement (TTM)|
|Cost of Revenue||CA$373.75k|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.008|
|Net Profit Margin||21.56%|
How did IOT perform over the long term?See historical performance and comparison
Is IOT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IOT?
Other financial metrics that can be useful for relative valuation.
|What is IOT's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does IOT's PE Ratio compare to its peers?
|IOT PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
IBT IBEX Technologies
J Lotus Ventures
EAST EastWest Bioscience
Price-To-Earnings vs Peers: IOT is expensive based on its Price-To-Earnings Ratio (20.5x) compared to the peer average (9.2x).
Price to Earnings Ratio vs Industry
How does IOT's PE Ratio compare vs other companies in the North American Life Sciences Industry?
Price-To-Earnings vs Industry: IOT is good value based on its Price-To-Earnings Ratio (20.5x) compared to the North American Life Sciences industry average (29.7x)
Price to Earnings Ratio vs Fair Ratio
What is IOT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||20.5x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate IOT's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of IOT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: IOT (CA$0.17) is trading above our estimate of fair value (CA$0.03)
Significantly Below Fair Value: IOT is trading above our estimate of fair value.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate IOT's PEG Ratio to determine if it is good value.
Discover undervalued companies
How is Innovotech forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Innovotech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
How has Innovotech performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IOT has a high level of non-cash earnings.
Growing Profit Margin: IOT's current net profit margins (21.6%) are higher than last year (17.7%).
Past Earnings Growth Analysis
Earnings Trend: IOT has become profitable over the past 5 years, growing earnings by -3% per year.
Accelerating Growth: IOT's earnings growth over the past year (28.2%) exceeds its 5-year average (-3% per year).
Earnings vs Industry: IOT earnings growth over the past year (28.2%) exceeded the Life Sciences industry 21.7%.
Return on Equity
High ROE: IOT's Return on Equity (27.3%) is considered high.
Discover strong past performing companies
How is Innovotech's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: IOT's short term assets (CA$917.2K) exceed its short term liabilities (CA$177.7K).
Long Term Liabilities: IOT's short term assets (CA$917.2K) exceed its long term liabilities (CA$14.9K).
Debt to Equity History and Analysis
Debt Level: IOT is debt free.
Reducing Debt: IOT currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Debt Coverage: IOT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: IOT has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Innovotech current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IOT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate IOT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IOT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IOT's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as IOT has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dr. James Timourian, Ph.D. has been the President of Innovotech Inc. since January 01, 2014 and serves as its Chief Executive Officer and Secretary. Dr. Timourian has been Mathematician, President of Integ...
Experienced Management: IOT's management team is considered experienced (2.5 years average tenure).
Experienced Board: IOT's board of directors are considered experienced (5.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Innovotech Inc.'s employee growth, exchange listings and data sources
- Name: Innovotech Inc.
- Ticker: IOT
- Exchange: TSXV
- Founded: 2001
- Industry: Life Sciences Tools and Services
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: CA$6.420m
- Shares outstanding: 38.91m
- Website: https://www.innovotech.ca
- Innovotech Inc.
- 2011-94 Street
- Suite L131
- T6N 1H1
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/29 00:00|
|End of Day Share Price||2022/06/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.